Navigation Links
Can multiple sclerosis attacks be minimized in a war zone?

Multiple sclerosis patients who directly confronted the stress of the Second Lebanon War suffered fewer attacks than those who chose to cope with the situation by focusing on feelings. This has been shown in a new study carried out by researchers of the University of Haifa, the Technion-Israel Institute of Technology and Carmel Medical Center. "Because there is no cure for multiple sclerosis to date, it is important to uncover all the factors that impact the recurrence of attacks," said Prof. Eli Somer of the University of Haifa, one of the authors of the study.

The study, which Prof. Somer carried out alongside Dr. Daniel Golan, Sara Dishon, Limor Cuzin-Disegni and Dr. Idit Lavi of Carmel Medical Center and Prof. Ariel Miller of the Technion, examined how MS patients living in the north of Israel coped during the Second Lebanon War. The results of the first stage of the study, which were recently published in the scientific journal Multiple Sclerosis, revealed that the ongoing stress of the war increased the number of MS attacks in patients who were exposed to rocket fire. The current stage of the study has examined 156 patients who have undergone regular therapy at the Center for Multiple Sclerosis at the Carmel Medical Center and who were living in the attacked north of Israel during the war.

The results have shown that patients who chose to use "direct coping and planning" to counter the stress factor by preparing the shelter or protected area, stocking up on food and medications, adjusting their medical appointment schedule, and the like suffered significantly less exacerbation of MS symptoms than patients who chose to cope with the situation on an emotional level, with relaxation techniques, requesting emotional support, or prayer.

"Patients who focused their coping on emotional wellbeing when a more direct approach was necessary, suffered more flare-ups of the disease than patients who identified the challenges that the falling missiles were presenting, and regarded the situation as an opportunity for planning and direct action," Prof. Somer noted.

The study has also found that women with MS tended to turn to emotional support, religion and willfully diverting thoughts more than men. Nevertheless, there was no difference between the numbers of men and women who chose "direct coping and planning".

"Coping directly is how a person takes real action in order to change an unwanted situation. Multiple sclerosis patients who chose to view the war as a controllable situation that requires action, instead of seeing it as an uncontrollable threat, suffered fewer attacks of the disease," said Prof. Somer, adding that now it is necessary to investigate whether the acquisition of psychological coping skills can stall the progression of this disease.


Contact: Rachel Feldman
University of Haifa

Related biology technology :

1. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
2. Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri
3. BioMS Medicals lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA
4. Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
5. Environmental Tectonics Corporation Announces a Multiple Sale for Monoplace Hyperbaric Chambers
6. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
7. Orexigen Therapeutics Announces Multiple Data Presentations at The Obesity Society Annual Scientific Meeting
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
10. Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
11. Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... SHPG ) announced today that Jeff Poulton , ... Annual Healthcare Conference in New York City ... (1:30 p.m. GMT). --> SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> Shire ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that the remaining 11,000 post-share consolidation (or 1,100,000 ... (the "Series B Warrants") subject to the previously ... November 23, 2015, which will result in the ... effect to the issuance of such shares, there ...
Breaking Biology Technology:
(Date:11/18/2015)... 18, 2015 --> ... new market report titled  Gesture Recognition Market - Global ... - 2021. According to the report, the global gesture recognition market was ... to reach US$29.1 bn by 2021, at a CAGR ... North America dominated the global gesture recognition ...
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
Breaking Biology News(10 mins):